Vascular morphology and permeability in fetal CNS grafts to the renal capsule.

Exp Neurol

Department of Anatomy, George Washington University, School of Medicine, Washington, D.C. 20037.

Published: June 1989

According to conventional neovascularization concepts, due to local tissue factors, a viable graft of central nervous (CNS) tissue should be expected to retain a complete blood-brain barrier (BBB) in its new site. In order to determine if grafted CNS would alter the phenotype of ingrowing peripheral vessels we have used an uncomplicated model. Rat fetal cortex, which already has a BBB to protein, was grafted to the subcapsular space of the host rat kidney. After postoperative times between 4 weeks and 3 months, horseradish peroxidase was injected systemically for periods between 90 s and 4 min. Correlative electron microscopy depicted vascular morphology. Each graft contained protein exudation particularly around large vessels in the neuropil. At the EM level some of the vascular endothelia had fenestrations, were invested with collagen, and were not contacted by astroglia. Capillaries indigenous to the CNS grafts and related normally to astroglial end feet were also prominent. The presence of non-CNS vessels with peripheral ultrastructural and permeability characteristics would appear to contradict conventional theory in that CNS grafts can be vascularized by vessels of a different phenotypic and physiologic nature.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0014-4886(89)90042-3DOI Listing

Publication Analysis

Top Keywords

cns grafts
12
vascular morphology
8
cns
5
morphology permeability
4
permeability fetal
4
fetal cns
4
grafts renal
4
renal capsule
4
capsule conventional
4
conventional neovascularization
4

Similar Publications

Advances and applications of genome-edited animal models for severe combined immunodeficiency.

Zool Res

January 2025

Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China. E-mail:

Severe combined immunodeficiency disease (SCID), characterized by profound immune system dysfunction, can lead to life-threatening infections and death. Animal models play a pivotal role in elucidating biological processes and advancing therapeutic strategies. Recent advances in gene-editing technologies, including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), CRISPR/Cas9, and base editing, have significantly enhanced the generation of SCID models.

View Article and Find Full Text PDF

CD4-Derived Double-Negative T Cells Ameliorate Alzheimer's Disease-Like Phenotypes in the 5×FAD Mouse Model.

CNS Neurosci Ther

January 2025

State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

Background: Alzheimer's disease (AD) is a debilitating neurodegenerative disorder that is difficult to predict and is typically diagnosed only after symptoms manifest. Recently, CD4 T cell-derived double-negative T (DNT) cells have shown strong immuno-regulatory properties in both in vitro and in vivo neuronal inflammation studies. However, the effectiveness of DNT cells in treating on AD are not yet fully understood.

View Article and Find Full Text PDF

Erdheim Chester Disease with Calvarial Involvement: A rare case of Histiocytosis.

Turk Neurosurg

March 2024

SBÜ Gaziosmanpaşa Eğitim ve Araştırma Hastanesi.

Erdheim-Chester Disease is a rare systemic xanthogranulomatous infiltrating disease, characterized by lipid-laden histiocytes accumulating in various organs and almost always in bones. Etiology of the disease is still unknown. It may involve various organs and systems, such as musculoskeletal, cardiac, pulmonary, renal, gastrointestinal and central nervous system (CNS) as well as the skin.

View Article and Find Full Text PDF

The chronic myeloid leukemia (CML) is easily diagnosed by laboratory examination, however, rare BCR-ABL1 mRNA transcripts variants, such as e1a3 present diagnosis and therapeutic challenges. This case report details the diagnosis and management of a CML patient with the e1a3 transcript by FISH and RT-PCR. Following initial diagnosis, the patient was treated with the tyrosine kinase inhibitor (TKI) Flumatinib.

View Article and Find Full Text PDF

Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Ann Hematol

January 2025

Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Peking University, Beijing, China.

Experience using olverembatinib as maintenance therapy in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph ALL) after allogeneic hematopoietic cell transplantation (allo-HCT) is limited. We retrospectively collected data from 26 patients with Ph ALL who received only olverembatinib as maintenance therapy after allo-HCT. Olverembatinib was administered as prophylaxis in 18 patients (69.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!